Bristol-Myers Squibb Co. (BMY)
BCBA
Closed
Aug 21, 2026
Day's Range
34,520.0052 wk Range
19,980.00Overview - BMY - Bristol-Myers Squibb Co.
Key Statistics
Valuation
Enterprise Value
108,953.65T
P/E (Trailing)
‪5.24‬
PEG Ratio
‪0.03‬
Price / Sales (TTM)
‪1,479.31‬
Price / Book
‪2.17‬
EV / EBITDA
‪3,845.50‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪31,657.20‬
200-Day Avg
‪29,026.00‬
Dividends
Payout Ratio
‪18.43%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BMY - Bristol-Myers Squibb Co.
Peers - BMY - Bristol-Myers Squibb Co.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BCBA.
- BMYBCBABristol-Myers Squibb Co.72.55TMarket Cap+40.10%52-week change5.14P/E (Trailing)‪18.87%‬Profit Margin
- SANBCBABanco Santander, S.A. CEDEAR1,355.89TMarket Cap+43.62%52-week change59.10P/E (Trailing)‪33.46%‬Profit Margin
- JNJBCBAJohnson & Johnson CEDEAR341.48TMarket Cap+44.54%52-week change11.12P/E (Trailing)‪21.48%‬Profit Margin
- GSKBCBAGlaxoSmithKline plc CEDEAR167.51TMarket Cap+35.56%52-week change17.31P/E (Trailing)‪14.52%‬Profit Margin
- AZNBCBAAstraZeneca PLC CEDEAR101.00TMarket Cap+18.54%52-week change6.36P/E (Trailing)‪17.02%‬Profit Margin
- ABBVBCBAAbbVie Inc. - Depositary Receipt74.64TMarket Cap+33.95%52-week change7.75P/E (Trailing)‪9.80%‬Profit Margin
- GILDBCBAGilead Sciences Inc.70.58TMarket Cap+32.98%52-week change4.84P/E (Trailing)‪-10.63%‬Profit Margin
Profile Summary - BMY - Bristol-Myers Squibb Co.
About
Bristol-Myers Squibb Co. is a globally renowned biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines. With a strong focus on serious diseases, the company's primary purpose is to address unmet medical needs in oncology, cardiovascular, immunoscience, and fibrosis through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
